Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 2129 - 2136 of 11616 results
What's New in 5G - March 2022
March 3, 2022| News
Health Law Diagnosed — Transactions Part 1: Regulatory Trends in Recent Health Care Transactions
March 3, 2022| Podcast| Viewpoint
What Does ESG Mean for Your Organization?
March 3, 2022| Webinar| Viewpoint
Patent Owner Tips for Avoiding IPR Institution
March 1, 2022| Blog| Viewpoint
Life-Changing Support Services Help Veterans Move Forward
February 28, 2022| Article| Viewpoint
Justices Bolster Copyrights With Decision Curbing Challenges
February 25, 2022| News
ML Strategies Energy & Sustainability Washington Updates - March 2022
February 25, 2022| Blog| Viewpoint
New York To Require Licensure of Pharmacy Benefit Managers
February 25, 2022| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.